Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Biomarkers of lymphoma in Sjögren's syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study.

Quartuccio L, Isola M, Baldini C, Priori R, Bartoloni Bocci E, Carubbi F, Maset M, Gregoraci G, Della Mea V, Salvin S, De Marchi G, Luciano N, Colafrancesco S, Alunno A, Giacomelli R, Gerli R, Valesini G, Bombardieri S, De Vita S.

J Autoimmun. 2014 Jun;51:75-80. doi: 10.1016/j.jaut.2013.10.002. Epub 2013 Nov 11.

PMID:
24231556
2.

Clinical and biological differences between cryoglobulinaemic and hypergammaglobulinaemic purpura in primary Sjögren's syndrome: results of a large multicentre study.

Quartuccio L, Isola M, Baldini C, Priori R, Bartoloni E, Carubbi F, Gregoraci G, Gandolfo S, Salvin S, Luciano N, Minniti A, Alunno A, Giacomelli R, Gerli R, Valesini G, Bombardieri S, De Vita S.

Scand J Rheumatol. 2015;44(1):36-41. doi: 10.3109/03009742.2014.923931. Epub 2014 Sep 30.

PMID:
25268749
3.

Anti-SSA/SSB-negative Sjögren's syndrome shows a lower prevalence of lymphoproliferative manifestations, and a lower risk of lymphoma evolution.

Quartuccio L, Baldini C, Bartoloni E, Priori R, Carubbi F, Corazza L, Alunno A, Colafrancesco S, Luciano N, Giacomelli R, Gerli R, Valesini G, Bombardieri S, De Vita S.

Autoimmun Rev. 2015 Nov;14(11):1019-22. doi: 10.1016/j.autrev.2015.07.002. Epub 2015 Jul 8. Review.

PMID:
26162302
4.

Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjögren's syndrome.

Theander E, Vasaitis L, Baecklund E, Nordmark G, Warfvinge G, Liedholm R, Brokstad K, Jonsson R, Jonsson MV.

Ann Rheum Dis. 2011 Aug;70(8):1363-8. doi: 10.1136/ard.2010.144782.

5.

A clinical prediction rule for lymphoma development in primary Sjögren's syndrome.

Baldini C, Pepe P, Luciano N, Ferro F, Talarico R, Grossi S, Tavoni A, Bombardieri S.

J Rheumatol. 2012 Apr;39(4):804-8. doi: 10.3899/jrheum.110754. Epub 2012 Feb 15.

PMID:
22337248
6.

Risk, predictors, and clinical characteristics of lymphoma development in primary Sjögren's syndrome.

Solans-Laqué R, López-Hernandez A, Bosch-Gil JA, Palacios A, Campillo M, Vilardell-Tarres M.

Semin Arthritis Rheum. 2011 Dec;41(3):415-23. doi: 10.1016/j.semarthrit.2011.04.006. Epub 2011 Jun 12.

PMID:
21665245
7.

[Prognostic implications of mixed monoclonal cryoglobulinemia in Sjogren's disease].

Vasil'ev VI, Probatova NA, Varlamova EIu, Tupitsin NN, Simonova MV, Safonova TN, Bozh'eva LA, Shornikova NS, Logvinenko OA, Belenin GIu.

Ter Arkh. 2004;76(8):61-8. Russian.

PMID:
15471400
9.

Clinical features distinguishing lymphoma development in primary Sjögren's Syndrome--a retrospective cohort study.

Risselada AP, Kruize AA, Bijlsma JW.

Semin Arthritis Rheum. 2013 Oct;43(2):171-7. doi: 10.1016/j.semarthrit.2013.03.001. Epub 2013 May 7.

PMID:
23664530
10.

Primary Sjögren's syndrome and B-non-Hodgkin lymphoma: role of CD4+ T lymphocytopenia.

Ismail F, Mahmoud A, Abdelhaleem H, Mamdoh A, Geneidy M, Kamal E.

Rheumatol Int. 2013 Apr;33(4):1021-5. doi: 10.1007/s00296-012-2464-7. Epub 2012 Aug 12.

PMID:
22886469
11.

B-cell activating factor genetic variants in lymphomagenesis associated with primary Sjogren's syndrome.

Nezos A, Papageorgiou A, Fragoulis G, Ioakeimidis D, Koutsilieris M, Tzioufas AG, Moutsopoulos HM, Voulgarelis M, Mavragani CP.

J Autoimmun. 2014 Jun;51:89-98. doi: 10.1016/j.jaut.2013.04.005. Epub 2013 Jul 9.

PMID:
23845207
12.

Clinical evolution, and morbidity and mortality of primary Sjögren's syndrome.

Skopouli FN, Dafni U, Ioannidis JP, Moutsopoulos HM.

Semin Arthritis Rheum. 2000 Apr;29(5):296-304.

PMID:
10805354
13.

Clinical picture, outcome and predictive factors of lymphoma in Sjӧgren syndrome.

Papageorgiou A, Voulgarelis M, Tzioufas AG.

Autoimmun Rev. 2015 Jul;14(7):641-9. doi: 10.1016/j.autrev.2015.03.004. Epub 2015 Mar 22. Review.

PMID:
25808075
14.

[Characteristics of the patients with primary Sjögren's syndrome complicated with lymphoma].

Li YQ, Yu QM, Li J, Yang JR, Niu T.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2012 May;43(3):467-9. Chinese.

PMID:
22812260
15.

[Characteristics of patients with primary Sjögren's syndrome and non-Hodgkin's lymphoma: analysis of 9 cases].

Jia N, Tang FL.

Zhonghua Yi Xue Za Zhi. 2009 Oct 27;89(39):2786-8. Chinese.

PMID:
20137605
16.

Sjögren's syndrome in patients with newly diagnosed untreated non-Hodgkin's lymphoma.

Andonopoulos AP, Tiniakou M, Melachrinou M, Sfountouris H, Bounas A, Zervas C, Zoumbos NC.

Rev Rhum Engl Ed. 1997 May;64(5):287-92. Review.

PMID:
9190001
17.

Primary Sjögren's syndrome in the North East of England: a long-term follow-up study.

Davidson BK, Kelly CA, Griffiths ID.

Rheumatology (Oxford). 1999 Mar;38(3):245-53.

PMID:
10325663
18.

Active immunological profile is associated with systemic Sjögren's syndrome.

Martel C, Gondran G, Launay D, Lalloué F, Palat S, Lambert M, Ly K, Loustaud-Ratti V, Bezanahary H, Hachulla E, Jauberteau MO, Vidal E, Hatron PY, Fauchais AL.

J Clin Immunol. 2011 Oct;31(5):840-7. doi: 10.1007/s10875-011-9553-3. Epub 2011 Jul 9.

PMID:
21744183
19.

Immunoglobulin gene rearrangements in lymphoplasmacytic infiltrates of labial salivary glands in Sjögren's syndrome. A possible predictor of lymphoma development.

Jordan R, Diss TC, Lench NJ, Isaacson PG, Speight PM.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995 Jun;79(6):723-9.

PMID:
7621030
20.

Clinicopathological factors relating malignant lymphoma with Sjögren's syndrome.

Anaya JM, McGuff HS, Banks PM, Talal N.

Semin Arthritis Rheum. 1996 Apr;25(5):337-46. Review.

PMID:
8778989

Supplemental Content

Support Center